0001209191-23-024500.txt : 20230417
0001209191-23-024500.hdr.sgml : 20230417
20230417172847
ACCESSION NUMBER: 0001209191-23-024500
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230413
FILED AS OF DATE: 20230417
DATE AS OF CHANGE: 20230417
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Szekeres David Leslie
CENTRAL INDEX KEY: 0001602459
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33221
FILM NUMBER: 23824895
MAIL ADDRESS:
STREET 1: C/O REGULUS THERAPEUTICS INC.
STREET 2: 3545 JOHN HOPKINS COURT, SUITE 210
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HERON THERAPEUTICS, INC. /DE/
CENTRAL INDEX KEY: 0000818033
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 942875566
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4242 CAMPUS POINT COURT, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8582514400
MAIL ADDRESS:
STREET 1: 4242 CAMPUS POINT COURT, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: AP PHARMA INC /DE/
DATE OF NAME CHANGE: 20010511
FORMER COMPANY:
FORMER CONFORMED NAME: ADVANCED POLYMER SYSTEMS INC /DE/
DATE OF NAME CHANGE: 19920703
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-04-13
0
0000818033
HERON THERAPEUTICS, INC. /DE/
HRTX
0001602459
Szekeres David Leslie
4242 CAMPUS POINT COURT
SUITE 200
SAN DIEGO
CA
92121
0
1
0
0
EVP, Chief Operating Officer
0
Common Stock
2023-04-13
4
M
0
1250
A
27400
D
Common Stock
2023-04-13
4
M
0
4564
A
31964
D
Common Stock
2023-04-13
4
F
0
2012
2.88
D
29952
D
Restricted Stock Units
2023-04-13
4
M
0
1250
0.00
D
Common Stock
1250
7500
D
Restricted Stock Units
2023-04-13
4
M
0
4564
0.00
D
Common Stock
4564
27936
D
Restricted stock units convert into common stock on a one-for-one basis.
Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions.
The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020).
The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021).
/s/ Lisa Peraza Attorney-in-fact for David Szekeres
2023-04-17